Clinical Trial Update: Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing IMN1207 to casein in non-small cell lung cancer was terminated; the update does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Casein (casein)
• IMN1207

Snippet

Sponsor: Immunotec Inc. | Conditions: NON-SMALL CELL LUNG CANCER | Phase 3 | Status: TERMINATED